Stockscreener 앱 받기
2.135
0.23%
0.005
전일 마감가:
$2.13
열려 있는:
$2.25
하루 거래량:
38,425
Relative Volume:
0.25
시가총액:
$56.80M
수익:
-
순이익/손실:
$-14.47M
주가수익비율:
-1.7218
EPS:
-1.24
순현금흐름:
$-12.19M
1주 성능:
-4.69%
1개월 성능:
-28.83%
6개월 성능:
-26.88%
1년 성능:
+11.78%
1일 변동 폭
$2.0959
$2.254
1주일 범위
$2.02
$2.3201
52주 변동 폭
$1.35
$3.48
Heartbeam Inc Stock (BEAT) Company Profile
명칭
Heartbeam Inc
전화
408-899-4443
주소
2118 WALSH AVE., SUITE 210, SANTA CLARA
BEAT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
2.14 | 56.80M | 0 | -14.47M | -12.19M | -1.24 |
|
VEEV
Veeva Systems Inc
|
216.62 | 35.09B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
68.17 | 11.80B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
52.98 | 9.75B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
100.19 | 8.68B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.26 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-09-11 | 개시 | Needham | Buy |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-08-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | 재확인 | Dougherty & Company | Buy |
| 2018-07-26 | 재확인 | Lake Street | Buy |
| 2018-04-26 | 재확인 | The Benchmark Company | Buy |
| 2018-02-23 | 재확인 | Dougherty & Company | Buy |
| 2017-11-08 | 재확인 | Dougherty & Company | Buy |
| 2017-10-26 | 개시 | Raymond James | Outperform |
| 2017-10-24 | 개시 | SunTrust | Buy |
| 2017-08-09 | 재확인 | Dougherty & Company | Buy |
| 2017-07-19 | 재확인 | The Benchmark Company | Buy |
| 2017-04-11 | 재확인 | Dougherty & Company | Buy |
| 2016-12-02 | 개시 | Dougherty & Company | Buy |
| 2016-09-13 | 개시 | Sidoti | Buy |
| 2016-08-03 | 재확인 | The Benchmark Company | Buy |
| 2015-07-28 | 재확인 | Dougherty & Company | Buy |
| 2013-10-24 | 개시 | The Benchmark Company | Buy |
| 2013-08-21 | 개시 | Dougherty & Company | Buy |
모두보기
Heartbeam Inc 주식(BEAT)의 최신 뉴스
JP Morgan Chase & Company (JPM-N) QuotePress Release - The Globe and Mail
HeartBeam (NASDAQ: BEAT) To Present At JP Morgan 2025 Annual Healthcare Conference - Barchart
Heartbeam Inc (BEAT-Q) QuotePress Release - The Globe and Mail
HeartBeam to Showcase FDA-Cleared Revolutionary Heart Monitor at JP Morgan Healthcare Conference - StockTitan
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference - Business Wire
HeartBeam’s arrhythmia assessment system gains FDA 510(k) clearance - Yahoo! Voices
FDA clearance adds glow to Heartbeam prospects - BioWorld Online
HeartBeam Wins FDA Nod for Home High-Fidelity Heart Monitor - MPO-mag
HeartBeam announces FDA clearance for high-fidelity ECG system - TipRanks
Heartbeam stock soars to 52-week high, hits $3.48 - Investing.com
FDA clears HeartBeam's novel ECG system for arrhythmia - Investing.com India
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology - Business Wire
HeartBeam And 2 Other US Penny Stocks With Promising Potential - Simply Wall St
The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times
HeartBeam rises on positive data from two studies on its vector-based technology - MSN
HeartBeam ECG technology shows promise in clinical studies By Investing.com - Investing.com Australia
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference - BioSpace
HeartBeam Touts Data from Study of Vector-Based Tech - MPO-mag
HeartBeam ECG technology shows promise in clinical studies - Investing.com India
HeartBeam announces positive data from two studies at AHA - TipRanks
HeartBeam, Inc. (NASDAQ:BEATW) Short Interest Update - Defense World
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2024 Earnings Call Transcript - Insider Monkey
HeartBeam (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Tech with FDA Submissions - Barchart
HeartBeam reports net loss of USD 5M in Q3 2024 - Medical Buyer
HeartBeam, Inc. Advances Cardiac Monitoring Solutions - TipRanks
HeartBeam Q3 Loss Widens to $5M as FDA Review Advances for Cardiac Tech | BEAT Stock News - StockTitan
Spotlight On US Penny Stocks In October 2024 - Simply Wall St
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time - Business Wire
Tripp Investments Alters Stake in Betmakers - MSN
Severfield PLC Executes Share Buy-Back on LSE - MSN
HeartBeam, Inc. (BEAT): A Bull Case Theory - Insider Monkey
HeartBeam (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care - Barchart
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards - Business Wire
HeartBeam Appoints Robert Eno as New CEO - TipRanks
Upstart Holdings, Inc. (UPST) Registers a Bigger Fall Than the Market: Important Facts to Note - MSN
Diamondback Energy (FANG) Rises Yet Lags Behind Market: Some Facts Worth Knowing - MSN
Lifesaving Portable, AI Augmented Cardiac Monitoring - openPR
HeartBeam names Robert Eno as new CEO for growth phase - Investing.com
HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization - Business Wire
HeartBeam Appoints Robert Eno as Chief Exec - MPO-mag
Dr. Lance Myers Joins HeartBeam As Chief AI Scientist - MPO-mag
Dr. Lance Myers Joins HeartBeam as Chief AI Scientist - MPO-mag
Short Interest in HeartBeam, Inc. (NASDAQ:BEATW) Decreases By 17.6% - Defense World
HeartBeam appoints AI expert Lance Myers as Chief Scientist - Investing.com
HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist - Business Wire
Here's Why We're Watching HeartBeam's (NASDAQ:BEAT) Cash Burn Situation - Simply Wall St
Is HeartBeam (NASDAQ:BEAT) In A Good Position To Invest In Growth? - Yahoo Finance
Timothy Cruickshank named HeartBeam CFO - Medical Buyer
Heartbeam stock retains Speculative Buy rating despite near-term risks - Investing.com India
HeartBeam Names Timothy Cruickshank As CFO - MPO-mag
Heartbeam Inc (BEAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.28%
자본화:
|
볼륨(24시간):